Jacques Morel

Treatment of Primary Sjögren Syndrome With Rituximab

Valérie Devauchelle‐Pensec, Xavier Mariette, Sandrine Jousse‐Joulin et al. · Annals of Internal Medicine · 2014 · 424 citations

Effects of Hydroxychloroquine on Symptomatic Improvement in Primary Sjögren Syndrome

Jacques‐Eric Gottenberg, Philippe Ravaud, Xavier Puéchal et al. · JAMA · 2014 · 294 citations

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 290 citations · Full text

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +9

Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease

Cem Gabay, Bruno Fautrel, Jürgen Rech et al. · Annals of the Rheumatic Diseases · 2018 · 284 citations · Full text

Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry

Dominique Salmon‐Céron, Florence Tubach, Olivier Lortholary et al. · Annals of the Rheumatic Diseases · 2010 · 280 citations